What smart money is saying about Neurocrine Biosciences, Inc.
NBIX
No fund has written a full thesis on Neurocrine Biosciences, Inc. in our archive, but 1 fund letter reports a position in it — most recently Brown Advisory U.S. Small-Cap Blend UCITS Fund in March 2026.
1
Reported positions
0
Bought
1
Sold
1
Letter
Position history
Every position in Neurocrine Biosciences, Inc. on record in the archive was reported in Q1 2026, across 1 fund letter — 1 trimmed or exited.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q1 2026 | 1 | 0 | 1 | 0 |
Fund activity · 1 position · 1 move
- March 2026
“We exited Neurocrine Biosciences, Inc. (NBIX) after the risk/reward no longer made sense.”
Read the letterNeurocrine Biosciences, Inc.
Read the letters behind these Neurocrine Biosciences, Inc. positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves — and to Warren AI, which reads all of them for you.
View plans→Share this ledger